HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis.

Abstract
We recently demonstrated that hepatic stellate cells induce the differentiation of myeloid-derived suppressor cells (MDSCs) from myeloid progenitors. In this study, we found that adoptive transfer of these MDSCs effectively reversed disease progression in experimental autoimmune myasthenia gravis (EAMG), a T cell-dependent and B cell-mediated model for myasthenia gravis. In addition to ameliorated disease severity, MDSC-treated EAMG mice showed suppressed acetylcholine receptor (AChR)-specific T cell responses, decreased levels of serum anti-AChR IgGs, and reduced complement activation at the neuromuscular junctions. Incubating MDSCs with B cells activated by anti-IgM or anti-CD40 Abs inhibited the proliferation of these in vitro-activated B cells. Administering MDSCs into mice immunized with a T cell-independent Ag inhibited the Ag-specific Ab production in vivo. MDSCs directly inhibit B cells through multiple mechanisms, including PGE2, inducible NO synthase, and arginase. Interestingly, MDSC treatment in EAMG mice does not appear to significantly inhibit their immune response to a nonrelevant Ag, OVA. These results demonstrated that hepatic stellate cell-induced MDSCs concurrently suppress both T and B cell autoimmunity, leading to effective treatment of established EAMG, and that the MDSCs inhibit AChR-specific immune responses at least partially in an Ag-specific manner. These data suggest that MDSCs could be further developed as a novel approach to treating myasthenia gravis and, even more broadly, other diseases in which T and B cells are involved in pathogenesis.
AuthorsYan Li, Zhidan Tu, Shiguang Qian, John J Fung, Sanford D Markowitz, Linda L Kusner, Henry J Kaminski, Lina Lu, Feng Lin
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 193 Issue 5 Pg. 2127-34 (Sep 01 2014) ISSN: 1550-6606 [Electronic] United States
PMID25057008 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 by The American Association of Immunologists, Inc.
Chemical References
  • Autoantibodies
  • Immunoglobulin G
  • Immunoglobulin M
  • Receptors, Nicotinic
  • Dinoprostone
Topics
  • Animals
  • Autoantibodies (immunology)
  • B-Lymphocytes (immunology, pathology)
  • Dinoprostone (immunology)
  • Hepatic Stellate Cells (immunology, pathology)
  • Immunoglobulin G (immunology)
  • Immunoglobulin M (immunology)
  • Mice
  • Myasthenia Gravis, Autoimmune, Experimental (immunology, pathology, therapy)
  • Myeloid Cells (immunology, pathology, transplantation)
  • Receptors, Nicotinic (immunology)
  • T-Lymphocytes (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: